Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
1-15 of 462
Integrating Molecular Testing into NSCLC Care
Project Oncology®Integrating Molecular Testing into NSCLC Care
Geoffrey Oxnard, MD
The Importance of Multidisciplinary Coordination in NSCLC Care
Project Oncology®The Importance of Multidisciplinary Coordination in NSCLC Care
Laura Alder, MD
The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Project Oncology®The Evolving Role of Antibody-Drug Conjugates in NSCLC Care
Raghava Reddy Induru, MD
Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Project Oncology®Antibody-Drug Conjugates for NSCLC: How They Work and Who’s a Candidate
Laura Alder, MD
Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Project Oncology®Key Questions Shaping Antibody-Drug Conjugate Use in NSCLC
Laura Alder, MD
Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Project Oncology®Emerging Biomarker Research for NSCLC Antibody-Drug Conjugates
Christine Bestvina, MD
- advertisement
Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Project Oncology®Managing Antibody-Drug Conjugate Toxicities in NSCLC Care
Laura Alder, MD
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®Smarter Screening for Non-Small Cell Lung Cancer
Jobelle Baldonado, MD
Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Project Oncology®Innovations Shaping the Future of Antibody-Drug Conjugates in NSCLC
Christine Bestvina, MD
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®A New Era of Hope in Non-Small Cell Lung Cancer Care
Geoffrey Oxnard, MD
Improving Adherence and Toxicity Monitoring in NSCLC Care
Project Oncology®Improving Adherence and Toxicity Monitoring in NSCLC Care
Raghava Reddy Induru, MD
Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Project Oncology®Tobacco-Related Stigma as a Barrier to Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
- advertisement
A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Project Oncology®A Patient-First Approach to Smoking Cessation and Lung Cancer Screening
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM
Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Project Oncology®Managing MAPK Inhibitor Adverse Events in Pediatric Low-Grade Gliomas
Alexandria May, PharmD, BCPS
Shannon Raber, MS, CPNP, RN
Bridget Archambault, MSN, CPNP
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Geoffrey Oxnard, MD
